Central Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.9M Sell
114,158
-785
-0.7% -$183K 0.55% 39
2025
Q4
$23.8M Sell
114,943
-2,860
-2% -$566K 0.47% 44
2025
Q3
$21.8M Sell
117,803
-1,998
-2% -$342K 0.46% 47
2025
Q2
$18.3M Sell
119,801
-1,278
-1% -$196K 0.42% 50
2025
Q1
$20.1M Sell
121,079
-3,701
-3% -$579K 0.49% 48
2024
Q4
$18M Sell
124,780
-9,687
-7% -$1.5M 0.44% 51
2024
Q3
$21.8M Sell
134,467
-6,529
-5% -$1.04M 0.51% 43
2024
Q2
$20.6M Sell
140,996
-15,203
-10% -$2.26M 0.5% 44
2024
Q1
$24.7M Sell
156,199
-4,377
-3% -$697K 0.62% 38
2023
Q4
$25.2M Sell
160,576
-5,506
-3% -$844K 0.67% 38
2023
Q3
$25.9M Sell
166,082
-1,217
-0.7% -$201K 0.75% 36
2023
Q2
$27.7M Sell
167,299
-3,181
-2% -$513K 0.77% 34
2023
Q1
$26.4M Buy
170,480
+545
+0.3% +$88K 0.77% 32
2022
Q4
$30M Buy
169,935
+1,824
+1% +$315K 0.93% 28
2022
Q3
$27.5M Buy
168,111
+1,550
+0.9% +$262K 0.94% 26
2022
Q2
$29.6M Sell
166,561
-1,863
-1% -$332K 0.98% 26
2022
Q1
$29.9M Sell
168,424
-4,086
-2% -$695K 0.85% 28
2021
Q4
$29.5M Sell
172,510
-2,873
-2% -$470K 0.83% 28
2021
Q3
$28.3M Sell
175,383
-7,570
-4% -$1.29M 1.01% 24
2021
Q2
$30.1M Buy
182,953
+526
+0.3% +$87.1K 1.09% 17
2021
Q1
$30M Buy
182,427
+8,469
+5% +$1.37M 1.17% 16
2020
Q4
$27.4M Buy
173,958
+923
+0.5% +$136K 1.12% 19
2020
Q3
$25.8M Buy
173,035
+1,004
+0.6% +$149K 1.17% 16
2020
Q2
$24.2M Buy
172,031
+697
+0.4% +$102K 1.21% 13
2020
Q1
$22.5M Buy
171,334
+3,576
+2% +$507K 1.38% 12
2019
Q4
$24.5M Sell
167,758
-2,461
-1% -$334K 1.25% 15
2019
Q3
$22M Sell
170,219
-5,547
-3% -$731K 1.24% 18
2019
Q2
$24.6M Sell
175,766
-11,133
-6% -$1.54M 1.4% 17
2019
Q1
$26.1M Sell
186,899
-713
-0.4% -$95.5K 1.56% 9
2018
Q4
$24.2M Buy
187,612
+336
+0.2% +$46.9K 1.61% 10
2018
Q3
$25.9M Buy
187,276
+305
+0.2% +$40.5K 1.5% 13
2018
Q2
$22.7M Sell
186,971
-1,780
-0.9% -$222K 1.45% 13
2018
Q1
$24.2M Buy
188,751
+19
+0% +$2.57K 1.54% 8
2017
Q4
$26.4M Sell
188,732
-102
-0.1% -$14.2K 1.61% 8
2017
Q3
$24.6M Sell
188,834
-4,040
-2% -$536K 1.59% 7
2017
Q2
$25.5M Sell
192,874
-4,158
-2% -$530K 1.69% 5
2017
Q1
$24.5M Sell
197,032
-5,070
-3% -$606K 1.63% 5
2016
Q4
$23.3M Buy
202,102
+6,523
+3% +$753K 1.6% 8
2016
Q3
$23.1M Sell
195,579
-10,056
-5% -$1.22M 1.68% 7
2016
Q2
$24.9M Sell
205,635
-3,934
-2% -$447K 1.87% 4
2016
Q1
$22.7M Buy
209,569
+1,900
+0.9% +$197K 1.79% 5
2015
Q4
$21.3M Buy
207,669
+836
+0.4% +$84.1K 1.76% 5
2015
Q3
$19.3M Buy
206,833
+2,477
+1% +$240K 1.68% 7
2015
Q2
$19.9M Sell
204,356
-10,782
-5% -$1.08M 1.57% 8
2015
Q1
$21.6M Buy
215,138
+6,492
+3% +$660K 1.74% 9
2014
Q4
$21.8M Sell
208,646
-12,195
-6% -$1.29M 1.78% 8
2014
Q3
$23.5M Sell
220,841
-1,092
-0.5% -$113K 1.87% 7
2014
Q2
$23.2M Sell
221,933
-2,969
-1% -$300K 1.83% 6
2014
Q1
$22.1M Buy
224,902
+3,451
+2% +$320K 1.83% 6
2013
Q4
$20.3M Sell
221,451
-2,824
-1% -$260K 1.7% 7
2013
Q3
$19.4M Buy
224,275
+5,387
+2% +$483K 1.76% 7
2013
Q2
$18.8M Buy
+218,888
New +$18.6M 1.78% 8

Other funds holding JNJ

Central Trust Company's JNJ Position: Q1 2026 in Review

Central Trust Company reduced its Johnson & Johnson (JNJ) stake by 0.68% in Q1 2026, selling an estimated $183K and leaving 114,158 shares worth $27.9M. The position accounts for 0.55% of the portfolio, ranked #39.

Central Trust Company first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.1M in Q2 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Central Trust Company held 114,158 shares of Johnson & Johnson worth $27.9M as of Q1 2026.
  • Central Trust Company sold 785 Johnson & Johnson shares in Q1 2026, an estimated $183K.
  • Johnson & Johnson made up 0.55% of Central Trust Company's portfolio in Q1 2026, its #39 holding.
  • Central Trust Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Johnson & Johnson position peaked at $30.1M in Q2 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.